{"brand":"Compound Laws","url":"https://compoundlaws.com/compounds/thca/federal/","compound":{"slug":"thca","name":"THCa"},"federal":[{"form":"all","status":"gray","headline":"THCa - federally contested: hemp on the statute's delta-9-only text, marijuana on DEA's post-decarboxylation reading; resolved against THCa ","tier":"under_review","schedule_class":null,"effective_date":"2018-12-20","verified_at":"2026-09-23","citations":[{"title":"7 U.S.C. 1639o - definition of hemp (Agricultural Marketing Act of 1946 sec. 297A)","url":"https://uscode.house.gov/view.xhtml?req=(title:7%20section:1639o%20edition:prelim)","pinpoint":null,"primary":true},{"title":"Pub. L. 119-37, div. B, tit. VII, sec. 781 (Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026; H.R. 5371), 139 Stat. 558","url":"https://www.govinfo.gov/content/pkg/PLAW-119publ37/html/PLAW-119publ37.htm","pinpoint":null,"primary":true},{"title":"Letter, Terrence L. Boos, Ph.D., Chief, Drug and Chemical Evaluation Section, DEA, to Shane Pennington, Porter Wright, May 13, 2024 (DEA ref. 24-9472) - THCA","url":"https://agri.ohio.gov/wps/wcm/connect/gov/4ebe6686-af1f-4020-b3cb-df25aabe2082/24-9472-porter-wright-thca-05032024-signed+(2).pdf?MOD=AJPERES&CONVERT_TO=url&CACHEID=ROOTWORKSPACE.Z18_K9I401S01H7F40QBNJU3SO1F56-4ebe6686-af1f-4020-b3cb-df25aabe2082-p1QiJx6","pinpoint":null,"primary":true},{"title":"7 CFR 990.1 - USDA Domestic Hemp Production Program definitions, acceptable hemp THC level and total THC","url":"https://www.ecfr.gov/current/title-7/section-990.1","pinpoint":null,"primary":true},{"title":"AK Futures LLC v. Boyd Street Distro, LLC, 35 F.4th 682 (9th Cir. 2022) (No. 21-56133)","url":"https://cdn.ca9.uscourts.gov/datastore/opinions/2022/05/19/21-56133.pdf","pinpoint":null,"primary":true},{"title":"Anderson v. Diamondback Investment Group, LLC (4th Cir. 2024) (No. 23-1400)","url":"https://www.ca4.uscourts.gov/opinions/231400.p.pdf","pinpoint":null,"primary":true},{"title":"21 CFR 1308.11 - Schedule I, including (d)(31) tetrahydrocannabinols (drug code 7370) and the (d)(31)(ii) hemp exclusion","url":"https://www.ecfr.gov/current/title-21/section-1308.11","pinpoint":null,"primary":true},{"title":"7 U.S.C. 1639o","url":"https://uscode.house.gov/view.xhtml?req=(title:7%20section:1639o%20edition:prelim)","pinpoint":null,"primary":true},{"title":"Federal Register full-text sweep, 2025-01-01 through 2026-07-25 (Federal Register API, agency and term filtered)","url":"https://www.federalregister.gov/api/v1/documents.json","pinpoint":null,"primary":false},{"title":"Statutory deadline for the Pub. L. 119-37 sec. 781(3) FDA cannabinoid lists (due on or about 2026-02-10) - not published as of 2026-07-25","url":"https://www.federalregister.gov/api/v1/documents.json","pinpoint":null,"primary":false},{"title":"UN Commission on Narcotic Drugs scheduling decisions, 68th session (March 2025) and 69th session (March 2026); WHO Expert Committee on Drug Dependence 47th and 48th meetings","url":"https://www.unodc.org/unodc/en/commissions/CND/Mandate_Functions/current-scheduling-decisions.html","pinpoint":null,"primary":false}]}]}